Robert Muni Lofra
Dr Anna Mayhew
Professor Chiara Marini Bettolo
| Assessing disease progression in spinal muscular atrophy, current gaps, and opportunities: a narrative review | 2025 |
|
Robert Muni Lofra
Dr Anna Mayhew
Professor Chiara Marini Bettolo
| Corrigendum to “Assessing disease progression in Spinal Muscular Atrophy, current gaps, and opportunities: a narrative review” [NMD, volume 49, article 105341] (Neuromuscular Disorders (2025) 49, (S0960896625000689), (10.1016/j.nmd.2025.105341)) | 2025 |
|
Dr Anna Mayhew
Catherine Turner
Jassi Sodhi
Meredith James
Adam Kerr
et al. | Delivery of physiotherapy and occupational therapy standards of care for Duchenne muscular dystrophy: Key recommendations based on UK web-based survey | 2025 |
|
Dr Marianela Schiava
Dr Claire Wood
Robert Muni Lofra
Dr Anna Mayhew
Professor Michela Guglieri
et al. | Height, weight, and body mass index trajectories and their correlation with functional outcome assessments in boys with Duchenne muscular dystrophy | 2025 |
|
Mark Richardson
Karen Wong
Dr Maha Elseed
Dionne Moat
Dr Lizzie Harris
et al. | Levels of exercise exposure among people living with neuromuscular disorders: lessons learned from real-world data | 2025 |
|
Professor Michela Guglieri
Professor Volker Straub
Dr Anna Mayhew
Emerita Professor Katherine Bushby
Robert Muni Lofra
et al. | Predicting trajectories of the north star ambulatory assessment total score in Duchenne muscular dystrophy | 2025 |
|
Dr Anna Mayhew
Professor Michela Guglieri
Professor Volker Straub
Robert Muni Lofra
| Visualizing ambulatory performance by age and rates of decline among patients with Duchenne muscular dystrophy | 2025 |
|
Dr Anna Mayhew
Robert Muni Lofra
Professor Chiara Marini Bettolo
| Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study | 2024 |
|
Dr Anna Mayhew
Robert Muni Lofra
Professor Chiara Marini Bettolo
| Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3 | 2024 |
|
Dr Marianela Schiava
Robert Muni Lofra
Dr John Bourke
Meredith James
Professor Jordi Diaz Manera
et al. | Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophy | 2024 |
|
Dr Marianela Schiava
Dr Anna Mayhew
Professor Michela Guglieri
| Factors Associated With Early Motor Function Trajectories in DMD After Glucocorticoid Initiation: Post Hoc Analysis of the FOR-DMD Trial | 2024 |
|
Dr Marianela Schiava
Dr John Bourke
Meredith James
Dr Maha Elseed
Dr Monika Malinova
et al. | Functional abilities, respiratory and cardiac function in a large cohort of adults with Duchenne muscular dystrophy treated with glucocorticoids | 2024 |
|
Dr Ursula Moore
Dr Anna Mayhew
Heather Hilsden
Dr Hai The Pham
Meredith James
et al. | Performance of upper limb entry item to predict forced vital capacity in dysferlin-deficient limb girdle muscular dystrophy | 2024 |
|
Dr Marianela Schiava
Dr Anna Mayhew
Professor Michela Guglieri
| Reference curves of motor function outcomes in young steroid-naïve males with Duchenne muscular dystrophy | 2024 |
|
Meredith James
Professor Michela Guglieri
Dr Anna Mayhew
| Understanding North Star Ambulatory Assessment total scores and their implications for standards of care using observational data | 2024 |
|
